The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development

zu Verbundenen Objekten

Abstract: Objective
Our objective was to develop an extension of the widely used GIN-McMaster Guideline Development Checklist and Tool for the integration of quality assurance and improvement (QAI) schemes with guideline development.

Study Design and Setting
We used a mixed-methods approach incorporating evidence from a systematic review, an expert workshop and a survey of experts to iteratively create an extension of the checklist for QAI through 3 rounds of feedback. As part of this process, we also refined criteria of a good guideline-based quality indicator.

Results
We developed a 40-item checklist extension addressing steps for the integration of QAI into guideline development across the existing 18 topics and created one new topic specific to QAI. The steps span from ‘organization, budget, planning and training’, to updating of QAI and guideline implementation.

Conclusions
The tool supports integration of QAI schemes with guideline development initiatives and it will be used in the forthcoming integrated European Commission Initiative on Colorectal Cancer. Future work should evaluate this extension and QAI items requiring additional support for guideline developers and links to QAI schemes

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
Journal of clinical epidemiology. - 154 (2023) , 197-203, ISSN: 1878-5921

Ereignis
Veröffentlichung
(wo)
Freiburg
(wer)
Universität
(wann)
2022
Urheber
Piggott, Thomas
Langendam, Miranda
Parmelli, Elena
Adolfsson, Jan
Akl, Elie A.
Armstrong, David
Braithwaite, Jeffrey
Brignardello-Petersen, Romina
Brożek, Jan L.
Follmann, Markus
Kopp, Ina
Meerpohl, Jörg J.
Neamţiu, Luciana
Nothacker, Monika Judith
Qaseem, Amir
Giorgi Rossi, Paolo
Saz-Parkinson, Zuleika
Wees, Philip J. van der
Schünemann, Holger J.

DOI
10.1016/j.jclinepi.2022.04.002
URN
urn:nbn:de:bsz:25-freidok-2266105
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
25.03.2025, 13:56 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

Entstanden

  • 2022

Ähnliche Objekte (12)

Wissenschaftliche Publikationspraxis in der klinischen Medizin : Wissenstransfer als Voraussetzung für evidenzbasierte Medizin

Hochschulschrift

Wissenschaftliche Publikationspraxis in der klinischen Medizin : Wissenstransfer als Voraussetzung für evidenzbasierte Medizin

Protocol for the development of the Chatbot Assessment Reporting Tool (CHART) for clinical advice

Protocol for the development of the Chatbot Assessment Reporting Tool (CHART) for clinical advice

Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance

Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance

Improving the trustworthiness of findings from nutrition evidence syntheses: assessing risk of bias and rating the certainty of evidence

Improving the trustworthiness of findings from nutrition evidence syntheses: assessing risk of bias and rating the certainty of evidence

Systematic reviews should be at the heart of continuing medical education

Systematic reviews should be at the heart of continuing medical education

GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence

GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence

Methodological quality of guidelines for management of Lyme neuroborreliosis

Methodological quality of guidelines for management of Lyme neuroborreliosis

Willingness to participate in, support or carry out scientific studies for benefit assessment of available medical interventions: a stakeholder survey

Willingness to participate in, support or carry out scientific studies for benefit assessment of available medical interventions: a stakeholder survey

The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days [version 2; peer review: 2 approved]

The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days [version 2; peer review: 2 approved]

Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE)

Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE)

Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: a repeated cross-sectional study

Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: a repeated cross-sectional study

Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design

Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design

Verbundene Objekte